Health
COVID-19 vaccine study has a warning for people who take common IBD drug – SlashGear
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower…
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD.
Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own immune system, resulting in the development of antibodies that help protect the individual from an infection caused by…
-
Noosa News23 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Noosa News22 hours agoMan charged with murder three days after death of 27-year-old in Livingstone, QLD
-
Business14 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News14 hours agoRent changes on way for hundreds of social housing recipients following government review